Galantamine for Metabolic Syndrome in Spinal Cord Injury
Part of Brain & nervous system, Hormones & metabolism, Injuries & trauma clinical trials.
This study tests whether a medication called galantamine can help improve metabolic syndrome (a cluster of health conditions including obesity, high blood sugar, and high cholesterol) in people with chronic spinal cord injury. The goal is to see if this treatment can reduce health risks and improve overall wellness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a spinal cord injury that occurred at least 1 year ago and is not getting worse
- You use a wheelchair for getting around in the community
- You have a large waist circumference (≥94 cm or about 37 inches) plus at least 2 other metabolic issues like high blood sugar, high triglycerides, or low HDL cholesterol
- Your resting heart rate is between 45 and 74 beats per minute
- Your heart function is normal based on an EKG test
- Your bowel function is manageable (not severe neurogenic bowel dysfunction)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a type of electrical stimulation on leg muscles can help control blood sugar levels in people with spinal cord injury. It compares results to those without injury to see if this treatment might improve health.
This study tests whether a non-invasive spinal cord stimulation device can help regulate blood pressure in people with spinal cord injury who have low blood pressure symptoms. It may help you feel less dizzy or faint when you sit or stand up.
This trial tests whether adding spinal cord stimulation to walking practice can improve leg movement and recovery after a recent spinal cord injury. It may help you regain more strength and function in your legs.
This study tests whether deep brain stimulation can improve walking in people with an incomplete spinal cord injury. It also requires that you meet specific injury and walking ability requirements and be able to attend study visits and training.
This early study tests a noninvasive way of training the nervous system to see how it affects “associative plasticity,” or the brain/spinal cord’s ability to change with practice. It may help researchers learn strategies that could improve function for people with spinal cord injury.
This trial tests whether metformin (a common diabetes drug) can reduce further damage to the spinal cord after a recent injury. If you have had a spinal cord injury in the last day, this study might help reduce long-term disability.
Hear when a new Traumatic Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.